| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.3 | 0.04 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.05 |